Cargando…

Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients

Liver biopsy is the gold standard for assessing fibrosis, but there is a need to seek non-invasive biomarkers for this purpose. The aim of this study was to evaluate the correlation between the serum levels of the microRNAs miR-21, miR-29a, miR-122, miR-155 and miR-181a and the phenotypic expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lima, Rodrigo Vieira Costa, Stefano, José Tadeu, Malta, Fernanda de Mello, Pinho, João Renato Rebello, Carrilho, Flair José, Arrese, Marco, Oliveira, Claudia P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698380/ https://www.ncbi.nlm.nih.gov/pubmed/34944567 http://dx.doi.org/10.3390/biomedicines9121751

Ejemplares similares

NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features
por: Recuero, Amanda Medeiros, et al.
Publicado: (2022)

Prevalence of naturally occurring NS5A resistance-associated substitutions in patients infected with hepatitis C virus subtype 1a, 1b, and 3a, co-infected or not with HIV in Brazil
por: Malta, Fernanda, et al.
Publicado: (2017)

Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review
por: Lee, Jenny, et al.
Publicado: (2021)

Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
por: Nones, Rodrigo Bremer, et al.
Publicado: (2017)

The impact of hepatitis E infection on hepatic fibrosis in liver transplanted patients for hepatitis C infection
por: de Moraes, Adriano Claudio Pereira, et al.
Publicado: (2021)

FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning
por: Ding, Yuping, et al.
Publicado: (2023)

Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil
por: Engel, Maricea, et al.
Publicado: (2007)

Updating the Phylodynamics of Yellow Fever Virus 2016–2019 Brazilian Outbreak With New 2018 and 2019 São Paulo Genomes
por: Moreira Salles, Ana Paula, et al.
Publicado: (2022)

FIB‑4 index and NAFLD fibrosis score are useful indicators for screening high‑risk groups of non‑viral hepatocellular carcinoma
por: Imai, Kenji, et al.
Publicado: (2023)

Hepatitis B (HBV), Hepatitis C (HCV) and Hepatitis Delta (HDV) Viruses in the Colombian Population—How Is the Epidemiological Situation?
por: Alvarado-Mora, Mónica Viviana, et al.
Publicado: (2011)

Accuracy of transient elastography-FibroScan(®), acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
por: Ragazzo, Taisa Grotta, et al.
Publicado: (2017)

Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4
por: John, Katharina, et al.
Publicado: (2022)

Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease
por: Unsal, İlknur Ozturk, et al.
Publicado: (2022)

Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population
por: Kolhe, Kailash Marotrao, et al.
Publicado: (2019)

1658. Lipase and Factor V (but not Viral Load) Are Prognostic Factors for the Evolution of Severe Yellow Fever Cases
por: Casadio, Luciana Vilas Boas, et al.
Publicado: (2019)

FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients
por: Metwally, Khaled, et al.
Publicado: (2020)

Lipase and factor V (but not viral load) are prognostic factors for the evolution of severe yellow fever cases
por: Casadio, Luciana Vilas Boas, et al.
Publicado: (2019)

Accuracy of Ultrasound Elastography and Fibrosis-4 Index (FIB-4) in Ruling Out Cirrhosis in Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
por: Damjanovska, Sofi, et al.
Publicado: (2022)

Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry
por: Passos-Castilho, Ana Maria, et al.
Publicado: (2015)

The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C
por: Oliveira, Arthur Ivan N., et al.
Publicado: (2021)

Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series
por: Alencar, Regiane Saraiva de Souza Melo, et al.
Publicado: (2022)

Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
por: Lonardo, Amedeo, et al.
Publicado: (2021)

FIB nanostructures
por: Wang, Zhiming M
Publicado: (2013)

Impact of Implementing a “FIB‐4 First” Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
por: Davyduke, Tracy, et al.
Publicado: (2019)

The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD
por: Kamada, Yoshihiro, et al.
Publicado: (2022)

Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
por: Li, Yijia, et al.
Publicado: (2020)

Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting
por: Blanco-Grau, Albert, et al.
Publicado: (2021)

Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center
por: Roh, Yun Hwa, et al.
Publicado: (2021)

Comparing Xe(+)pFIB and Ga(+)FIB for TEM sample preparation of Al alloys: Minimising FIB‐induced artefacts
por: Zhong, Xiangli, et al.
Publicado: (2020)

Vitamin C and Vitamin E in Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in Choline Deficient Diet Fed Rats
por: Oliveira, Claudia PMS, et al.
Publicado: (2003)

Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
por: Kumari, Bandana, et al.
Publicado: (2021)

Characterization of Hepatitis B virus (HBV) genotypes in patients from Rondônia, Brazil
por: Santos, Alcione O, et al.
Publicado: (2010)

FIB the fractured femur
por: Shahzad, H, et al.
Publicado: (2013)

FibH Gene Complete Sequences (FibHome) Revealed Silkworm Pedigree
por: Lu, Wei, et al.
Publicado: (2023)

Distribution of hepatitis c virus (hcv) genotypes in patients with chronic infection from Rondônia, Brazil
por: Vieira, Deusilene S, et al.
Publicado: (2011)

Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease
por: Moini, Maryam, et al.
Publicado: (2021)

Distribution of hepatitis B virus subgenotype F2a in São Paulo, Brazil
por: Alvarado-Mora, Mónica V, et al.
Publicado: (2013)

Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)

Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy
por: Hernández, Alejandra, et al.
Publicado: (2020)

Micronuclei formation in liver fibrosis samples from patients infected by hepatitis C virus
por: de Almeida, Terezinha M. B., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h961qf3vla20lgs1clcl63o64n